![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: STRAP |
Gene summary for STRAP |
![]() |
Gene information | Species | Human | Gene symbol | STRAP | Gene ID | 11171 |
Gene name | serine/threonine kinase receptor associated protein | |
Gene Alias | MAWD | |
Cytomap | 12p12.3 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | Q9Y3F4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11171 | STRAP | HTA11_347_2000001011 | Human | Colorectum | AD | 9.37e-04 | 1.97e-01 | -0.1954 |
11171 | STRAP | HTA11_866_3004761011 | Human | Colorectum | AD | 2.23e-03 | 2.32e-01 | 0.096 |
11171 | STRAP | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.26e-03 | 3.04e-01 | 0.294 |
11171 | STRAP | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 4.28e-05 | 1.09e+00 | 0.3487 |
11171 | STRAP | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.20e-05 | 3.82e-01 | 0.3859 |
11171 | STRAP | A015-C-203 | Human | Colorectum | FAP | 8.08e-03 | -1.23e-01 | -0.1294 |
11171 | STRAP | A001-C-108 | Human | Colorectum | FAP | 8.16e-04 | -1.55e-01 | -0.0272 |
11171 | STRAP | A015-C-104 | Human | Colorectum | FAP | 8.22e-04 | -1.38e-01 | -0.1899 |
11171 | STRAP | A002-C-116 | Human | Colorectum | FAP | 2.38e-03 | -1.18e-01 | -0.0452 |
11171 | STRAP | F034 | Human | Colorectum | FAP | 1.81e-03 | -1.69e-01 | -0.0665 |
11171 | STRAP | AEH-subject2 | Human | Endometrium | AEH | 5.68e-04 | -2.12e-01 | -0.2525 |
11171 | STRAP | AEH-subject3 | Human | Endometrium | AEH | 2.38e-06 | -1.90e-01 | -0.2576 |
11171 | STRAP | AEH-subject4 | Human | Endometrium | AEH | 6.60e-03 | -1.68e-01 | -0.2657 |
11171 | STRAP | EEC-subject1 | Human | Endometrium | EEC | 7.70e-06 | -1.28e-01 | -0.2682 |
11171 | STRAP | EEC-subject2 | Human | Endometrium | EEC | 3.22e-07 | -2.98e-01 | -0.2607 |
11171 | STRAP | EEC-subject3 | Human | Endometrium | EEC | 7.51e-25 | -2.94e-01 | -0.2525 |
11171 | STRAP | EEC-subject4 | Human | Endometrium | EEC | 5.83e-04 | -2.21e-01 | -0.2571 |
11171 | STRAP | GSM5276937 | Human | Endometrium | EEC | 1.88e-16 | 3.91e-01 | -0.0897 |
11171 | STRAP | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 1.35e-24 | -2.53e-01 | -0.1869 |
11171 | STRAP | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 1.23e-19 | -1.75e-01 | -0.1875 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00003872 | Liver | HCC | spliceosomal snRNP assembly | 31/7958 | 50/18723 | 4.23e-03 | 1.84e-02 | 31 |
GO:002261320 | Oral cavity | OSCC | ribonucleoprotein complex biogenesis | 333/7305 | 463/18723 | 8.28e-48 | 5.24e-44 | 333 |
GO:000838020 | Oral cavity | OSCC | RNA splicing | 308/7305 | 434/18723 | 2.43e-42 | 7.70e-39 | 308 |
GO:000037519 | Oral cavity | OSCC | RNA splicing, via transesterification reactions | 225/7305 | 324/18723 | 5.20e-29 | 2.99e-26 | 225 |
GO:000037719 | Oral cavity | OSCC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 221/7305 | 320/18723 | 5.50e-28 | 2.18e-25 | 221 |
GO:000039819 | Oral cavity | OSCC | mRNA splicing, via spliceosome | 221/7305 | 320/18723 | 5.50e-28 | 2.18e-25 | 221 |
GO:007182620 | Oral cavity | OSCC | ribonucleoprotein complex subunit organization | 152/7305 | 227/18723 | 1.05e-17 | 1.01e-15 | 152 |
GO:002261820 | Oral cavity | OSCC | ribonucleoprotein complex assembly | 146/7305 | 220/18723 | 1.53e-16 | 1.23e-14 | 146 |
GO:00715598 | Oral cavity | OSCC | response to transforming growth factor beta | 140/7305 | 256/18723 | 2.34e-07 | 3.70e-06 | 140 |
GO:00715608 | Oral cavity | OSCC | cellular response to transforming growth factor beta stimulus | 137/7305 | 250/18723 | 2.68e-07 | 4.15e-06 | 137 |
GO:000038016 | Oral cavity | OSCC | alternative mRNA splicing, via spliceosome | 51/7305 | 77/18723 | 1.19e-06 | 1.59e-05 | 51 |
GO:00071798 | Oral cavity | OSCC | transforming growth factor beta receptor signaling pathway | 109/7305 | 198/18723 | 3.21e-06 | 3.86e-05 | 109 |
GO:00170155 | Oral cavity | OSCC | regulation of transforming growth factor beta receptor signaling pathway | 71/7305 | 128/18723 | 1.14e-04 | 8.34e-04 | 71 |
GO:19038446 | Oral cavity | OSCC | regulation of cellular response to transforming growth factor beta stimulus | 72/7305 | 131/18723 | 1.51e-04 | 1.06e-03 | 72 |
GO:00071789 | Oral cavity | OSCC | transmembrane receptor protein serine/threonine kinase signaling pathway | 165/7305 | 355/18723 | 2.31e-03 | 1.02e-02 | 165 |
GO:00003874 | Oral cavity | OSCC | spliceosomal snRNP assembly | 28/7305 | 50/18723 | 1.10e-02 | 3.72e-02 | 28 |
GO:0022613110 | Oral cavity | LP | ribonucleoprotein complex biogenesis | 259/4623 | 463/18723 | 7.20e-48 | 2.25e-44 | 259 |
GO:0008380110 | Oral cavity | LP | RNA splicing | 237/4623 | 434/18723 | 1.82e-41 | 3.79e-38 | 237 |
GO:0000375110 | Oral cavity | LP | RNA splicing, via transesterification reactions | 181/4623 | 324/18723 | 1.36e-33 | 1.70e-30 | 181 |
GO:0000377110 | Oral cavity | LP | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 179/4623 | 320/18723 | 2.48e-33 | 2.22e-30 | 179 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
STRAP | SNV | Missense_Mutation | c.996A>T | p.Glu332Asp | p.E332D | Q9Y3F4 | protein_coding | tolerated_low_confidence(0.35) | benign(0) | TCGA-BH-A18V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
STRAP | insertion | Nonsense_Mutation | novel | c.821_822insATCAAATGAAGTCTGTGAGGGATATTAGAGATAAAGGAGAT | p.Ser274ArgfsTer10 | p.S274Rfs*10 | Q9Y3F4 | protein_coding | TCGA-AN-A049-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
STRAP | SNV | Missense_Mutation | novel | c.397N>A | p.Glu133Lys | p.E133K | Q9Y3F4 | protein_coding | deleterious(0.04) | benign(0.164) | TCGA-C5-A1ME-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
STRAP | SNV | Missense_Mutation | rs185224819 | c.724N>A | p.Gly242Ser | p.G242S | Q9Y3F4 | protein_coding | tolerated(0.06) | benign(0.397) | TCGA-EA-A3HS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
STRAP | SNV | Missense_Mutation | c.853N>C | p.Glu285Gln | p.E285Q | Q9Y3F4 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-IR-A3LK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | PD | |
STRAP | SNV | Missense_Mutation | c.130N>T | p.Arg44Cys | p.R44C | Q9Y3F4 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AD-6895-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
STRAP | SNV | Missense_Mutation | c.49G>A | p.Val17Met | p.V17M | Q9Y3F4 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AZ-6599-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
STRAP | SNV | Missense_Mutation | novel | c.562N>C | p.Ser188Arg | p.S188R | Q9Y3F4 | protein_coding | deleterious(0) | possibly_damaging(0.83) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
STRAP | SNV | Missense_Mutation | novel | c.910N>G | p.Lys304Glu | p.K304E | Q9Y3F4 | protein_coding | deleterious(0.01) | possibly_damaging(0.51) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
STRAP | SNV | Missense_Mutation | rs752651730 | c.374G>A | p.Arg125His | p.R125H | Q9Y3F4 | protein_coding | deleterious(0.03) | benign(0.303) | TCGA-AG-A02N-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Chemotherapy | folinic | CR |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
11171 | STRAP | KINASE | ADJUVANT | 15720808 |
Page: 1 |